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ABSTRACT
Assessment of compliance in drug taking is
a problem in a crowded Outpatient Department.
Using riboflavin as a urinary marker is a simple
and rational method. Identifying riboflavin in
the urine by fluorescence on exposure to ultra-
violet (UV) rays or torch light is being used in
medical practice but not extensively. In this
study, the validity and reliability of these meth-
ods were assessed. The sensitivity and specificity
of this test by UV method was 86% and 82% for
Reader I (medical person) and 82% and 94% for
Reader II (paramedical person). For Reader 1, the
accuracy of reading by UV lamp was the same as
torch light (85%) whereas for Reader II the accu-
racy was better with UV lamp (87%) than with
torch (79%). In reading the fluorescence by UV
lamp the crude agreement between the 2 readers
was 82% and chance corrected agreement was
64%. UV lamp method appears to be a reliable
way of assessing compliance both by medical and
paramedical persons whereas torch method ap-
pears to be more reliable when used by a medical
person than by a paramedical person.
Key words: Compliance, Riboflavin, UV lamp
method.
The major problem in chronic drug
therapy whether it is the treatment of
epilepsy or tuberculosis is poor compli-
ance. Most often compliance is often
verified in a busy Outpatient Depart-
ment from the parental history. Pill
counting is not possible as many pa-
tients do not bring the drug container
because either they are so illiterate or
they do not want to disclose their
irregularity in drug intake.
In the management of epilepsy, com-
pliance needs to be verified especially in
situations where adjustment of drug
dosage is required. History alone from
an ignorant, illiterate parent may not
give the true position. Estimation of
drug level would be more accurate but
it is expensive and time consuming and
is not carried out in all the hospitals in
our country.
Hence, it is important to have a
simple, inexpensive and less time con-
suming bed side test to assess compli-
ance. If a pharmacologically inert sub-
stance, which can be readily detected in
an accessible body fluid, is added to the
tablet under investigation, then screen-
ing of the body fluid for the inert
substance would provide a technically
simple test. Riboflavin, on oral adminis-
tration, is absorbed in the upper gastro-
intestinal tract, bound to plasma protein
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in the blood and excreted in the urine as
the free vitamin. This may be detected
qualitatively in the urine by its fluores-
cence on exposure to ultraviolet light. It
does not cause adverse pharmacological
effects(1-3).
To assess compliance, in this study
we utilized riboflavin tablets with or
without active medication and screened
the urine of these patients for fluores-
cence under ultraviolet (UV) lamp and
torch light. The study had the following
objectives : (i) To assess the validity of
this test in identifying children who
have taken riboflavin; (ii) To find out the
inter observer variation in reading the
fluorescence effect; and (iii) To deter-
mine the minimal dose of riboflavin re-
quired to produce fluorescence in the
urine sample 12 to 14 hours after inges-
tion.
Subjects and Methods
Two methods were used to assess
the presence of fluorescence in urine.
1. UV lamp method (4): Fluorescence
was tested by exposing the urine to
ultra violet light using a “ADCO cabinet
type model UV-BT long wave length
lamp”. Urine was placed in a wide bot-
tomed beaker with water in a similar
beaker as control. When a milky white
fluorescence was observed, the test was
said to be positive, otherwise it was
considered negative.
2. Another documented method is
examining urine, in a universal blood
tube, for fluorescence by a narrow beam
of light emanating from a pen torch
against a matt black background(5).
Though this is a coarse method, its ad-
vantage is that only specimens showing
high levels of riboflavin will be positive.
Forty four (44) children in the age
group 4-12 years were recruited and
randomized into two groups. One
group was advised to take riboflavin
tablet at 9 PM and to attend hospital at
9 AM the next day. The other group was
advised not to take any tablet and to
attend the hospital the next day. Five
children belonging to the second group
did not attend the hospital the next day.
The volunteers were children attending
seizure clinic and their siblings. No
dietary restriction was imposed on the
children but they were asked to avoid
all medication from 24 hours prior to
taking the riboflavin tablet till the com-
pletion of the test. Those on anti epilep-
tic drugs were advised to continue the
drugs. The urine samples from children
who consumed riboflavin and from
those who did not consume riboflavin
were numbered and arranged in a ran-
dom sequence by a third investigator.
The coding of the sequence was kept in
a file. A medical and a paramedical per-
son were then asked to screen the urine
by both methods, independently and
give their results. They were totally
blind to the knowledge of riboflavin
consumption by children. Their results
were tabulated.
In order to find out the minimal dos-
age of riboflavin required to produce
fluorescence in urine, we recruited 75
children separately in the age group 4-
12 years. These also included patients
attending the seizure clinic and their
siblings. These children were divided
into 3 groups of 25 children each. The
first group was instructed to take 10 mg
of riboflavin at 9PM, the second group
to take 20 mg of riboflavin at 9 PM and
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the third group to take 30mg of ribofla-
vin at 9 PM. They were all asked to re-
port at 9 AM the next day. Samples of
urine were collected at 9 AM, 10 AM
and 11 AM for all 75 children. All the
samples were tested for fluorescence by
a medical officer using UV lamp
method.
Results
Data from 39 volunteers were used
for calculating test characteristics like
sensitivity, specificity, positive predic-
tive value and negative predictive value
for both UV method and torch method.
Inter-observer variation was calculated
by kappa statistics. Data from 75 differ-
ent volunteers were used to calculate
the proportion of patients whose urine
was positive for fluorescence test, at
variable intervals after ingestion of ribo-
flavin. Proportion of patients who had
positive tests in three groups consuming
10 mg, 20 mg and 30 mg, respectively
were calculated.
When UV lamp method was used,
sensitivity of the test was 86% for
Reader I (medical officer) and 82% for
Reader II (paramedial person). The
specificity of this test was 82% and 94%
and the positive predictive values were
86% and 95% for Readers I and II,
respectively. When torch method was
used, sensitivity of the test was 86% for
Reader I and 68% for Reader II. The
specificity of this test was 82% and 94%
and the positive predictive values were
86% and 94% for Readers I and II,
respectively. For Reader I, accuracy of
reading by UV lamp was the same as
torch light (85%), whereas for Reader II,
the accuracy was better with W lamp
(87%) than with torch (79%).
The presence of riboflavin in the
urine was identified by Reader I, by
both methods, in 18 out of 22 patients
given riboflavin. Reader II identified ri-
boflavin by both methods in 15 samples.
The absence of fluorescence in the urine
was identified by Reader I, by both
methods, in 13 out of 17 patients who
were not given riboflavin. Reader II
identified absence of fluorescence in the
urine, by both methods in 15 out of 17
samples (Table I).
When test results of W lamp
method were compared between Read-
ers I and II, 32 observations agreed out
of 39. The crude agreement was 82%
(Table II) and chance corrected agree-
ment (Kappa) was 64%. When test re-
sults of torch method were compared
between Readers I and II, 33 observa-
tions agreed out of 39. The crude agree-
ment was 85% (Table III) and chance
corrected agreement (Kappa) was 70%.
All 75 patients showed fluorescence
upto 13 hours after consumption of ri-
boflavin. For those who received 30 mg,
88% showed positive test even at 14
hours whereas among children who re-
ceived 20 mg, only 52% showed positive
test at the end of 14 hours. Of children
who received 10 mg, only 32% showed
fluorescence at the end of 14 hours.
Discussion
Assessment of compliance using ri-
boflavin as a urinary marker is a techni-
cally simple and rational method. It is
quick, non-invasive and can be carried
out for any drug. This test could be
done either in the Out Patient Depart-
ment or at the bedside, both by a medi-
cal and by a non medical person(4-6).
In our study, the accuracy of UV
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TABLE I - Identification of Fluorescence by UV Method and Torch Method
Riboflavin
taken
Reader No. of children in whom fluorescence was observed by
Both UV UV Torch Neither
& torch only only torch nor UV
Yes
(n=22)
I 18 1 0 3
II 15 3 0 4
No. of children in whom fluorescence was not observed by
Both UV UV Torch Neither
& torch only only torch nor UV
I 13 0 1 3
No
(n=17) II 15 1 1 0
TABLE II- Inter Observer Variation-UV TABLE III - Inter Observer Variation-Torch
Method Method
Reader II Reader I
Positive Negative Total
Reader II Reader I
Positive Negative Total
Positive 17
Negative 5
Total 22
2 19
15 20
17 39
Positive 16 0 16
Negative 6 17 23
Total 22 17 39
lamp method for the two readers was
85% and 87% and for torch method it
was 85% and 79%, respectively. The
inter-observer agreement as assessed by
Kappa statistic was moderate. The
study by Jones also revealed the accu-
racy of torch method to be 92%(5).
In the group that ingested 30 mg of
riboflavin, a high proportion (88%)
showed positive urine results at 14
hours whereas in the group that re-
ceived 10 mg, a very low proportion
(32%) showed fluorescence at the end of
14 hours. The higher the amount of ribo-
flavin ingested, the greater is the pro-
portion detected as riboflavin positive.
Similarly riboflavin can be detected in
the urine for a longer period when more
is ingested. A minimal dose of 10 mg is
adequate to detect riboflavin in the
urine upto 13 hours in all patients.
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Similar observations have been made by
other authors(7).
A limitation to this technique is that
occasional false positive and false. nega-
tive results can occur. False positive
readings could occur due to increased
ingestion of foods containing riboflavin.
False negative readings could be due to
fast urinary excretion of the vitamin.
The presence of phosphates and cells in
the urine can impair its translucency
and make reading difficult. Addition of
acetic acid clears phosphates and cells
usually settle down if left for half an
hour(5).
It is possible for the patient who con-
sciously sets out to mislead the clinician
and who knows about the method, to
succeed by taking a tablet or two before
he is seen, but this is not likely to he a
common phenomenon. Probably, fac-
tors at a much less conscious level are
responsible for irregular medication,
and perhaps this method will allow
some of these factors to be investi-
gated(5).
In conclusion, we recommend that
W lamp method be adapted to assess
compliance of drug intake in any situa-
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tion where long term therapy is
required. Torch method appears to be
less accurate then W method.
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Your response to the ‘Opinion Poll’ published in January 1995 issue is
eagerly awaited to finalise the future shape of your journal.
– Editor-in-Chief
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